Jeff E. Knight - 31 Dec 2022 Form 5 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Chief Operating Officer
Signature
/s/ Marc Wilson
Issuer symbol
CRNX
Transactions as of
31 Dec 2022
Net transactions value
+$8,141
Form type
5
Filing time
27 Jan 2023, 15:27:37 UTC
Previous filing
29 Jul 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Other $8,141 +537 +11% $15.16 5,487 20 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),